Matt Thalman

Matt received his Undergraduate Degree from West Virginia University and his MBA from the University of Phoenix. After living on the West Coast for a number of years, Matt moved back east and now lives in Northern Virginia. Matt has been writing since 2011, but his love for the markets began after learning about the power of compound interest while studying business in college. Matt mainly focuses on consumer-facing stocks and general investing topics, but will cover other areas of the markets if he believes there is something important investors need to know.

Follow him on Twitter at @mthalman5513 to get his most up-to-date articles and opinions about the market.

Recent Articles

DAL Stock: Don’t Believe Delta’s Shiny Earnings

Delta earnings beat the Street, sure, but DAL stock is rebounding on share buybacks and lower energy costs, not real growth.

Johnson & Johnson Earnings Are Better Than They Look (JNJ)

The latest Johnson & Johnson earnings report is better than it looks on the surface. Here's a closer look at what that means for JNJ stock.

Should I Buy Johnson & Johnson? 3 Pros and 3 Cons (JNJ)

We look at 3 positives and 3 negatives for JNJ stock to help you decide whether it's time to buy or better to just stay away.

TWTR: 5 Things Holding Twitter Stock Back

Weak earnings, no direction and a question mark over its CEO? Twitter stock has no shortage of reasons for investors to steer clear.

Smith & Reloads Despite Weak Guidance (SWHC)

SWHC stock stumbled briefly after earnings, but an analyst upgrade helped spur a quick recovery for the gun stock.